BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Embryo
,
Holistic medicine
,
Lipitor
,
rs2300478
,
PDX1
,
calcium channel activity
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
bile acid- coa ligase
Summary
General Info
Curated Studies
Most Correlated Studies
OMIM - Congenital disorder
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
Explore Curated Studies Results
Literature
Most Relevant Literature
Loss of SLC27A5 Activates Hepatic Stellate Cells and Promotes Liver Fibrosis via Unconjugated Cholic…
FATP5 Is Indispensable for the Growth of Intrahepatic Cholangiocarcinoma.
SLC27A5 promotes sorafenib-induced ferroptosis in hepatocellular carcinoma by downregulating glutath…
Metabolic Enzyme SLC27A5 Regulates PIP4K2A pre-mRNA Splicing as a Noncanonical Mechanism to Suppress…
Copper metabolism-related risk score identifies hepatocellular carcinoma subtypes and SLC27A5 as a p…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for bile acid- coa ligase
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ